Skip to content

Researchers hope psilocybin could improve quit rates for smokers

Gary Enos

Alcoholism & Drug Abuse Weekly November 19, 2021 DOI: 10.1002/adaw.33270 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Multisite study Peer reviewed
Intervention Psilocybin
Topics Addiction Psilocybin
Keywords Wonder Nicotine addiction Smoking cessation Population Hallucinogen
Key points Current treatments for nicotine addiction have no better than a 30% success rate, and a new multisite study of psilocybin for smoking cessation is underway.

Abstract

With nicotine being one of the most addictive substances and the available treatments for nicotine addiction leading to no better than a 30% success rate, it's no wonder that a newly announced multisite study of the psychedelic psilocybin for smoking cessation is generating excitement. While taking care not to oversell the potential of this strategy, those involved with the research hope at least that a large study with a diverse population will help identify who might eventually benefit most from the alternative approach.

Explore topics